Cellectis SA (CLLS)
3.55
-0.11
(-3.01%)
USD |
NASDAQ |
May 21, 16:00
3.55
0.00 (0.00%)
After-Hours: 19:59
Cellectis Research and Development Expense (TTM) : 80.74M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| DBV Technologies SA | 119.79M |
| Grifols SA | 471.52M |
| Akari Therapeutics Plc | 3.464M |
| Biodexa Pharmaceuticals Plc | 5.234M |
| NuCana Plc | 19.05M |